Ligand validation:2CL5

BU3: (R,R)-2,3-BUTANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2CL5_BU3_B_1219	93%	83%	0.064	0.966	0.39	0.34	-	-	0	0	100%	1
2CL5_BU3_A_1219	66%	71%	0.105	0.91	0.58	0.4	-	-	0	0	100%	1
2CL5_BU3_A_1220	41%	74%	0.129	0.844	0.36	0.54	-	-	0	0	100%	1
9F92_BU3_A_305	99%	72%	0.039	0.987	0.34	0.61	-	-	0	0	100%	1
5JRH_BU3_B_705	99%	86%	0.039	0.986	0.28	0.37	-	-	0	0	100%	1
9LB2_BU3_A_712	99%	75%	0.045	0.989	0.6	0.28	-	-	3	0	100%	1
3O5C_BU3_C_701	98%	79%	0.048	0.982	0.39	0.41	-	-	0	0	100%	1
4AAN_BU3_A_1347	98%	69%	0.051	0.983	0.39	0.63	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.